** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525

** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14

** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year

** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year

** Says revenue growth driven by capital sales and new site activations

** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares

** Stock up 13.2% YTD, including current session's moves

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))